Compare

EUDA Health Holdings Ltd vs Vsee Health, Inc. vs Omada Health, Inc. vs GeneDx Holdings Corp.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearEUDA Health Holdings Ltd
EUDA
Vsee Health, Inc.
VSEE
Omada Health, Inc.
OMDA
GeneDx Holdings Corp.
WGS
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$6.82M$14.62M$260.21M$427.54M
Revenue growth (YoY)+70.0%+40.3%+53.2%+40.0%
Gross margin43.9%50.3%65.7%69.7%
Operating margin-36.3%-65.6%-4.6%-3.1%
Net margin-40.7%-100.6%-4.9%-4.9%
Net income-$2.77M-$14.71M-$12.78M-$21.02M
EPS (Diluted)-$1.48-$0.73-$0.35-$0.73
Operating cash flow-$2.43M-$3.45M$18.25M$33.28M
Free cash flow-$2.50M-$3.48M$16.93M$14.26M
Cash & equivalentsn/a$5.27M$222.04M$105.00M
Total assets$1.72M$22.41M$305.41M$523.71M
Total liabilities$5.98M$16.96M$75.73M$215.53M
Shareholders' equity-$4.25M$5.45M$229.68M$308.18M
Return on year-end equityn/a-269.8%-5.6%-6.8%
Shares outstanding1.89M33.19M58.43M29.25M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearEUDA Health Holdings LtdVsee Health, Inc.Omada Health, Inc.GeneDx Holdings Corp.
Latest$6.82M
Ended 2025-12-31
$14.62M
Ended 2025-12-31
$260.21M
Ended 2025-12-31
$427.54M
Ended 2025-12-31
1 year earlier$4.01M
Ended 2024-12-31
$10.42M
Ended 2024-12-31
$169.80M
Ended 2024-12-31
$305.45M
Ended 2024-12-31
2 years earlier$3.71M
Ended 2023-12-31
$5.77M
Ended 2023-12-31
$122.78M
Ended 2023-12-31
$202.57M
Ended 2023-12-31
3 years earlier$3.76M
Ended 2022-12-31
n/an/a$234.69M
Ended 2022-12-31
4 years earlier$4.56M
Ended 2021-12-31
n/an/a$212.19M
Ended 2021-12-31